Serum 25-hydroxyvitamin D predicts severity and prognosis in stroke patients

European Journal of Neurology

Volumn 20, Issue 1, 2013, Pages 57-61

  Daubail, B ^a   Jacquin, A ^a   Guilland, J C ^a   Hervieu, M ^a   Osseby, G V ^a   Rouaud, O ^a   Giroud, M ^a   Bejot Y ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Acute stroke; Functional recovery; Outcome; Prognosis; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D;

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; VITAMIN BLOOD LEVEL;

AGE FACTORS; AGED; DISEASE PROGRESSION; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; STROKE; VITAMIN D;

EID: 84871644371     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2012.03758.x     Document Type: Article

References (22)

1. McGreevy C, Williams D. New insights about vitamin d and cardiovascular disease: a narrative review. Ann Intern Med 2011; 155: 820-826.
2. Poole KE, Loveridge N, Barker PJ, et-al. Reduced vitamin D in acute stroke. Stroke 2006; 37: 243-245.
3. Carda S, Cisari C, Invernizzi M, Bevilacqua M. Osteoporosis after stroke: a review of the causes and potential treatments. Cerebrovasc Dis 2009; 28: 191-200.
4. Buell JS, Dawson-Hughes B, Scott TM, et-al. 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 2010; 74: 18-26.
5. Carrelli AL, Walker MD, Lowe H, et-al. Vitamin D deficiency is associated with subclinical carotid atherosclerosis: the Northern Manhattan study. Stroke 2011; 42: 2240-2245.
6. Pilz S, Dobnig H, Fischer JE, et-al. Low vitamin d levels predict stroke in patients referred to coronary angiography. Stroke 2008; 39: 2611-2613.
7. Wang TJ, Pencina MJ, Booth SL, et-al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008; 117: 503-511.
8. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 2008; 168: 1174-1180.
9. WHO. The World Health Report 2000: Health Systems Improving Performance. Geneva: WHO, 2000.
10. Adams HP Jr, Bendixen BH, Kappelle LJ, et-al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
11. Ovbiagele B, Saver JL. Day-90 acute ischemic stroke outcomes can be derived from early functional activity level. Cerebrovasc Dis 2010; 29: 50-56.
12. Bejot Y, Caillier M, Ben Salem D, et-al. Ischaemic stroke subtypes and associated risk factors: a French population based study. J Neurol Neurosurg Psychiatry 2008; 79: 1344-1348.
13. Liu LC, Voors AA, van Veldhuisen DJ, et-al. Vitamin D status and outcomes in heart failure patients. Eur J Heart Fail 2011; 13: 619-625.
14. Pilz S, Iodice S, Zittermann A, et-al. Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am J Kidney Dis 2011; 58: 374-382.
15. Zittermann A, Iodice S, Pilz S, Grant WB, Bagnardi V, Gandini S. Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr 2012; 95: 91-100.
16. Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Pr, 2010. www.iom.edu/Activities/Nutrition/DRIVitDCalcium/2010-NOV-30.aspx (accessed 23/02/2012).
17. Pilz S, Tomaschitz A, Drechsler C, Zittermann A, Dekker JM, März W. Vitamin D supplementation: a promising approach for the prevention and treatment of strokes. Curr Drug Targets 2011; 12: 88-96.
18. Kalueff AV, Tuohimaa P. Neurosteroid hormone vitamin D and its utility in clinical nutrition. Curr Opin Clin Nutr Metab Care 2007; 10: 12-19.
19. Wang Y, Chiang YH, Su TP, et-al. Vitamin D(3) attenuates cortical infarction induced by middle cerebral arterial ligation in rats. Neuropharmacology 2000; 39: 873-880.
20. Kajta M, Makarewicz D, Ziemińska E, et-al. Neuroprotection by co-treatment and post-treating with calcitriol following the ischemic and excitotoxic insult in vivo and in vitro. Neurochem Int 2009; 55: 265-274.
21. Elamin MB, Abu Elnour NO, Elamin KB, et-al. Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011; 96: 1931-1942.
22. Manson JE, Bassuk SS, Lee IM, et-al. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials 2012; 33: 159-171.